Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Neuralgia × nabiximols × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 2 Neuralgia 1 Multiple Sclerosis 1 Marijuana Abuse 1 Diabetes Mellitus 1

Interventions

Surveys and Questionnaires 2 nabiximols 1 Tapentadol 1 Plastic Surgery Procedures 1 Oxycodone 1 Morphine 1 Methadone 1 Hydromorphone 1 Fentanyl 1 Buprenorphine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02073474 2022-12-20

An Observational Post-Marketing Safety Registry of Sativex®

Jazz Pharmaceuticals

Marijuana Abuse, Diabetes Mellitus, Multiple Sclerosis, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡